Neil A Klompas

Insider

First SEC filing: March 14, 2023 · Latest: March 14, 2023

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 8 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

8 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Dec. 19, 2025	INM	A	1,750	—	—	5,250 Direct	+50.00%	Acquired	(price as of 2026-08-19)
Oct. 17, 2025	INM	A	3,500	—	—	3,500 Direct	—	Acquired	(price as of 2026-08-19)
March 10, 2023	ZYME	M	2,708	—	—	2,709 Direct	-49.99%	Disposed	(price as of 2026-08-19)
March 10, 2023	ZYME	M	2,500	—	—	0 Direct	-100.00%	Disposed	(price as of 2026-08-19)
March 10, 2023	ZYME	S	2,977	$7.83	$23,310	17,032 Direct	-14.88%	Disposed	253.7% (price as of 2026-08-19)
March 10, 2023	ZYME	M	2,708	—	—	20,009 Direct	+15.65%	Acquired	(price as of 2026-08-19)
March 10, 2023	ZYME	M	2,500	—	—	17,301 Direct	+16.89%	Acquired	(price as of 2026-08-19)
Jan. 5, 2023	ZYME	A	58,500	—	—	58,500 Direct	—	Acquired	(price as of 2026-08-19)
Jan. 5, 2023	ZYME	A	87,500	—	—	87,500 Direct	—	Acquired	(price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Dec. 19, 2025	INM	Employee Stock Option (Right to Buy)	Common shares (1,750)	$1.29	Dec. 18, 2030	1,750	Acquired
Oct. 17, 2025	INM	Employee Stock Option (Right to Buy)	Common shares (3,500)	$2.10	Oct. 16, 2030	3,500	Acquired
March 10, 2023	ZYME	Restricted Stock Unit	Common Stock (2,708)	—	—	2,708	Disposed
March 10, 2023	ZYME	Restricted Stock Unit	Common Stock (2,500)	—	—	2,500	Disposed
Jan. 5, 2023	ZYME	Restricted Stock Unit	Common Stock (58,500)	—	—	58,500	Acquired
Jan. 5, 2023	ZYME	Stock Option (Right to Buy)	Common Stock (87,500)	$8.00	Jan. 4, 2033	87,500	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Former President & COO(12)

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2023	$321,568	—	—	—	—	—	$1,007,801	$2,125,732
2022	$503,795	—	—	—	$330,699	—	$23,878	$1,808,408
2021	$437,124	—	—	—	—	—	$2,277	$1,900,478

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.